Amgen Could Block Enbrel Biosimilars For Another Decade As Court Rules Stealth Patents Valid

 
• By Brenda Sandburg
  
Tumor-necrosis
Court finds patents covering the TNF-IgG1 immunoglobulin fusion protein are valid.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics